Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (9) , 2886-2890
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Novel echinocandin antifungals. Part 1: Novel side-chain analogs of the natural product FR901379Bioorganic & Medicinal Chemistry Letters, 2008
- Increasing Fungal Infections in the Intensive Care UnitSurgical Infections, 2006
- Antifungal Therapy: Lessons Learned over the Past 27 YearsClinical Infectious Diseases, 2006
- Advances and challenges in management of invasive mycosesThe Lancet, 2005
- Some aspects of the osmotic lysis of erythrocytes III. Comparison of glycerol permeability and lipid composition of red blood cell membranes from eight mammalian speciesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2003
- From natural products to clinically useful antifungalsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological propertiesBioorganic & Medicinal Chemistry Letters, 2001
- WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties.The Journal of Antibiotics, 1994
- WF11899A, B and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties.The Journal of Antibiotics, 1994
- Deacylation of echinocandin B by Actinoplanes utahensis.The Journal of Antibiotics, 1989